-
1
-
-
0025853048
-
Receptor-mediated immunomodulation by corticotropin-releasing factor
-
Audhya T., Jain R., Hollander C.S. (1991) Receptor-mediated immunomodulation by corticotropin-releasing factor. Cell Immunol 134(1):77-84.
-
(1991)
Cell Immunol
, vol.134
, Issue.1
, pp. 77-84
-
-
Audhya, T.1
Jain, R.2
Hollander, C.S.3
-
2
-
-
0028845881
-
Identification and characterization of a corticotrophin-releasing hormone receptor in human placenta
-
Clifton V.L., Owens P.C., Robinson P.J., Smith R. (1995) Identification and characterization of a corticotrophin-releasing hormone receptor in human placenta. Eur J Endocrinol 133:591-597.
-
(1995)
Eur J Endocrinol
, vol.133
, pp. 591-597
-
-
Clifton, V.L.1
Owens, P.C.2
Robinson, P.J.3
Smith, R.4
-
3
-
-
0028914020
-
Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart
-
Perrin M., et al. (1995) Identification of a second corticotropin- releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 92:2969-2973.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 2969-2973
-
-
Perrin, M.1
-
4
-
-
1442303287
-
Corticotropin-Releasing Hormone System in Human Adipose Tissue
-
DOI 10.1210/jc.2003-031299
-
Seres J., et al. (2004) Corticotropin-releasing hormone system in human adipose tissue. J Clin Endocrinol Metab 89:965-970. (Pubitemid 38269919)
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, Issue.2
, pp. 965-970
-
-
Seres, J.1
Bornstein, S.R.2
Seres, P.3
Willenberg, H.S.4
Schulte, K.M.5
Scherbaum, W.A.6
Ehrhart-Bornstein, M.7
-
5
-
-
77955443500
-
Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets
-
Ludwig B., et al. (2010) Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets. Proc Natl Acad Sci USA 107:12623-12628.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 12623-12628
-
-
Ludwig, B.1
-
6
-
-
76249111443
-
CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner
-
Huising M.O., et al. (2010) CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner. Proc Natl Acad Sci USA 107:912-917.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 912-917
-
-
Huising, M.O.1
-
7
-
-
78650844968
-
Glucocorticoids differentially regulate the expression of CRFR1 and CRFR2α in MIN6 insulinoma cells and rodent islets
-
Huising M.O., et al. (2011) Glucocorticoids differentially regulate the expression of CRFR1 and CRFR2α in MIN6 insulinoma cells and rodent islets. Endocrinology 152:138-150.
-
(2011)
Endocrinology
, vol.152
, pp. 138-150
-
-
Huising, M.O.1
-
8
-
-
33744995524
-
2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells
-
DOI 10.1016/j.peptides.2006.01.011, PII S0196978106000696
-
Kageyama K., et al. (2006) Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells. Peptides 27:1814-1819. (Pubitemid 43866281)
-
(2006)
Peptides
, vol.27
, Issue.7
, pp. 1814-1819
-
-
Kageyama, K.1
Kimura, R.2
Suga, S.3
Ogawa, Y.4
Suda, T.5
Wakui, M.6
-
9
-
-
0032832623
-
2+ influx in rat pancreatic beta-cells
-
DOI 10.2337/diabetes.48.9.1741
-
Kanno T., Suga S., Nakano K., Kamimura N., Wakui M. (1999) Corticotropin-releasing factor modulation of Ca2+ influx in rat pancreatic beta-cells. Diabetes 48:1741-1746. (Pubitemid 29415192)
-
(1999)
Diabetes
, vol.48
, Issue.9
, pp. 1741-1746
-
-
Kanno, T.1
Suga, S.2
Nakano, K.3
Kamimura, N.4
Wakui, M.5
-
10
-
-
43849102318
-
Vasopressin potentiates corticotropin-releasing hormone-induced insulin release from mouse pancreatic beta-cells
-
DOI 10.1677/JOE-07-0645
-
O'Carroll A.M., Howell G.M., Roberts E.M., Lolait S.J. (2008) Vasopressin potentiates corticotropin-releasing hormone-induced insulin release from mouse pancreatic beta-cells. J Endocrinol 197:231-239. (Pubitemid 351696236)
-
(2008)
Journal of Endocrinology
, vol.197
, Issue.2
, pp. 231-239
-
-
O'Carroll, A.-M.1
Howell, G.M.2
Roberts, E.M.3
Lolait, S.J.4
-
11
-
-
79953186050
-
Increased pituitary-adrenal activation and shortened gestation in a sample of depressed pregnant women: A pilot study
-
O'Keane V., et al. (2011) Increased pituitary-adrenal activation and shortened gestation in a sample of depressed pregnant women: A pilot study. J Affect Disord 130:300-305.
-
(2011)
J Affect Disord
, vol.130
, pp. 300-305
-
-
O'Keane, V.1
-
12
-
-
77954819097
-
Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes
-
Yi S.S., et al. (2010) Regulatory mechanism of hypothalamo-pituitary- adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes. J Chem Neuroanat 40(2):130-139.
-
(2010)
J Chem Neuroanat
, vol.40
, Issue.2
, pp. 130-139
-
-
Yi, S.S.1
-
13
-
-
80051962389
-
Stress as an influencing factor in psoriasis
-
Heller M.M., Lee E.S., Koo J.Y. (2011) Stress as an influencing factor in psoriasis. Skin Therapy Lett 16(5):1-4.
-
(2011)
Skin Therapy Lett
, vol.16
, Issue.5
, pp. 1-4
-
-
Heller, M.M.1
Lee, E.S.2
Koo, J.Y.3
-
14
-
-
1642423789
-
Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides
-
DOI 10.1210/en.2003-1023
-
Brar B.K., Chen A., Perrin M.H., Vale W. (2004) Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides. Endocrinology 145:1718-1729. (Pubitemid 38402380)
-
(2004)
Endocrinology
, vol.145
, Issue.4
, pp. 1718-1729
-
-
Brar, B.K.1
Chen, A.2
Perrin, M.H.3
Vale, W.4
-
15
-
-
0021437995
-
Thyroid hormones, gonadal and adrenocortical steroids and the function of the islets of Langerhans
-
Lenzen S., Bailey C.J. (1984) Thyroid hormones, gonadal and adrenocortical steroids and the function of the islets of Langerhans. Endocr Rev 5:411-434.
-
(1984)
Endocr Rev
, vol.5
, pp. 411-434
-
-
Lenzen, S.1
Bailey, C.J.2
-
17
-
-
0025371914
-
Immunohistochemical localization of the glucocorticoid receptor in pancreatic beta-cells of the rat
-
Fischer B., et al. (1990) Immunohistochemical localization of the glucocorticoid receptor in pancreatic beta-cells of the rat. Endocrinology 126:2635-2641. (Pubitemid 20173057)
-
(1990)
Endocrinology
, vol.126
, Issue.5
, pp. 2635-2641
-
-
Fischer, B.1
Rausch, U.2
Wollny, P.3
Westphal, H.4
Seitz, J.5
Aumuller, G.6
-
18
-
-
0032611267
-
11 beta-hydroxysteroid dehydrogenase
-
Stewart P.M., Krozowski Z.S. (1999) 11 beta-hydroxysteroid dehydrogenase. Vitam Horm 57:249-324.
-
(1999)
Vitam Horm
, vol.57
, pp. 249-324
-
-
Stewart, P.M.1
Krozowski, Z.S.2
-
19
-
-
0347064002
-
Increased expression and activity of 11beta-HSD-1 in diabetic islets and prevention with troglitazone
-
DOI 10.1016/j.bbrc.2003.11.160
-
Duplomb L., et al. (2004) Increased expression and activity of 11beta-HSD-1 in diabetic islets and prevention with troglitazone. Biochem Biophys Res Commun 313:594-599. (Pubitemid 38021871)
-
(2004)
Biochemical and Biophysical Research Communications
, vol.313
, Issue.3
, pp. 594-599
-
-
Duplomb, L.1
Lee, Y.2
Wang, M.-Y.3
Park, B.H.4
Takaishi, K.5
Agarwal, A.K.6
Unger, R.H.7
-
20
-
-
0036432995
-
Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
-
DOI 10.1007/s00125-002-0959-6
-
Alberts P., et al. (2002) Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 45:1528-1532. (Pubitemid 35352046)
-
(2002)
Diabetologia
, vol.45
, Issue.11
, pp. 1528-1532
-
-
Alberts, P.1
Engblom, L.2
Edling, N.3
Forsgren, M.4
Klingstrom, G.5
Larsson, C.6
Ronquist-Nii, Y.7
Ohman, B.8
Abrahmsen, L.9
-
21
-
-
78649719548
-
11β-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus
-
Hollis G., Huber R. (2011) 11β-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus. Diabetes Obes Metab 13(1):1-6.
-
(2011)
Diabetes Obes Metab
, vol.13
, Issue.1
, pp. 1-6
-
-
Hollis, G.1
Huber, R.2
-
22
-
-
0029989854
-
Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: Studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone
-
DOI 10.1007/s001250050573
-
Lindsay R.S., Lindsay R.M., Waddell B.J., Seckl J.R. (1996) Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: Studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone. Diabetologia 39:1299-1305. (Pubitemid 26356057)
-
(1996)
Diabetologia
, vol.39
, Issue.11
, pp. 1299-1305
-
-
Lindsay, R.S.1
Lindsay, R.M.2
Waddell, B.J.3
Seckl, J.R.4
-
23
-
-
84857458591
-
-
Available at Accessed July 27, 2011
-
Houssay B.A. (1949) Nobel Lecture. Available at http://nobelprize.org/ nobel-prizes/medicine/laureates/1947/houssay-lecture.html. Accessed July 27, 2011.
-
(1949)
Nobel Lecture
-
-
Houssay, B.A.1
-
24
-
-
0020631097
-
Corticotropin-releasing factor (CRF)-like immunoreactivity in the vertebrate endocrine pancreas
-
Petrusz P., Merchenthaler I., Maderdrut J.L., Vigh S., Schally A.V. (1983) Corticotropin-releasing factor (CRF)-like immunoreactivity in the vertebrate endocrine pancreas. Proc Natl Acad Sci USA 80:1721-1725. (Pubitemid 13136419)
-
(1983)
Proceedings of the National Academy of Sciences of the United States of America
, vol.80
, Issue.6 I
, pp. 1721-1725
-
-
Petrusz, P.1
Merchenthaler, I.2
Maderdrut, J.L.3
-
25
-
-
3042594442
-
Impaired leptin expression and abnormal response to fasting in corticotropin-releasing hormone-deficient mice
-
DOI 10.1210/en.2003-1558
-
Jeong K.H., Sakihara S., Widmaier E.P., Majzoub J.A. (2004) Impaired leptin expression and abnormal response to fasting in corticotropin-releasing hormone-deficient mice. Endocrinology 145:3174-3181. (Pubitemid 38829988)
-
(2004)
Endocrinology
, vol.145
, Issue.7
, pp. 3174-3181
-
-
Jeong, K.-H.1
Sakihara, S.2
Widmaier, E.P.3
Majzoub, J.A.4
-
26
-
-
34047235651
-
Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands
-
DOI 10.1055/s-2007-961811
-
Krause K., Schnitger A., Fimmel S., Glass E., Zouboulis C.C. (2007) Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res 39(2):166-170. (Pubitemid 46535575)
-
(2007)
Hormone and Metabolic Research
, vol.39
, Issue.2
, pp. 166-170
-
-
Krause, K.1
Schnitger, A.2
Fimmel, S.3
Glass, E.4
Zouboulis, C.C.5
-
27
-
-
77950331167
-
Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men
-
Van Raalte D.H., et al. (2010) Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men. Eur J Endocrinol 162:729-735.
-
(2010)
Eur J Endocrinol
, vol.162
, pp. 729-735
-
-
Van Raalte, D.H.1
-
28
-
-
77955590502
-
11Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes
-
Morgan S.A., Tomlinson J.W. (2010) 11Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes. Expert Opin Investig Drugs 19:1067-1076.
-
(2010)
Expert Opin Investig Drugs
, vol.19
, pp. 1067-1076
-
-
Morgan, S.A.1
Tomlinson, J.W.2
-
29
-
-
77950664531
-
11Beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: Status and development
-
Ge R., Huang Y., Liang G., Li X. (2010) 11Beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: Status and development. Curr Med Chem 17:412-422.
-
(2010)
Curr Med Chem
, vol.17
, pp. 412-422
-
-
Ge, R.1
Huang, Y.2
Liang, G.3
Li, X.4
-
30
-
-
0034634085
-
Type 1 11beta-hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets
-
Davani B., et al. (2000) Type 1 11beta-hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets. J Biol Chem 275:34841-34844.
-
(2000)
J Biol Chem
, vol.275
, pp. 34841-34844
-
-
Davani, B.1
-
31
-
-
3142718884
-
Hypothalamic regulation of adiposity: The role of 11beta-hydroxysteroid dehydrogenase type 1
-
DOI 10.1055/s-2004-814570
-
Hochberg Z., Friedberg M., Yaniv L., Bader T., Tiosano D. (2004) Hypothalamic regulation of adiposity: The role of 11beta-hydroxysteroid dehydrogenase type 1. Horm Metab Res 36:365-369. (Pubitemid 38932091)
-
(2004)
Hormone and Metabolic Research
, vol.36
, Issue.6
, pp. 365-369
-
-
Hochberg, Z.1
Friedberg, M.2
Yaniv, L.3
Bader, T.4
Tiosano, D.5
-
32
-
-
0028815089
-
Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need
-
Muglia L., Jacobson L., Dikkes P., Majzoub J.A. (1995) Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373:427-432.
-
(1995)
Nature
, vol.373
, pp. 427-432
-
-
Muglia, L.1
Jacobson, L.2
Dikkes, P.3
Majzoub, J.A.4
|